What LABCORP HOLDINGS INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 3 | 22 |
| Total trades | 7 | 151 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 870 | 144,096 |
| Disposed | 3,696 | 96,372 |
| Net activity | −2,826 | +47,724 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Caveney Brian J | EVP, Pres of BLS, CMO & CSO | Nov 10 | Open-market sale · S | −2,000 | $372.04 | −$744K | 34,562 |
| Vaughn Bryan T | EVP and President, Diagnostics | Nov 03 | Open-market sale · S | −306 | $353.70 | −$108K | 6,845 |
| Vaughn Bryan T | EVP and President, Diagnostics | Nov 02 | Withheld — tax / exercise cost · F | −194 | $355.59 | −$69K | 7,151 |
| Oyegunwa Akinbolade | EVP, CIO & CTO | Nov 02 | Withheld — tax / exercise cost · F | −118 | $355.59 | −$42K | 5,316 |
| Vaughn Bryan T | EVP and President, Diagnostics | Nov 01 | Exercise / conversion · M | +500 | — | — | 7,345 |
| Oyegunwa Akinbolade | EVP, CIO & CTO | Nov 01 | Exercise / conversion · M | +370 | — | — | 5,434 |
| Parham Richelle P | Director | Oct 30 | Open-market sale · S | −1,078 | $361.22 | −$389K | 2,288 |
| Anderson Kerrii B | Director | Aug 17 | Open-market sale · S | −3,000 | $318.02 | −$954K | 6,563 |
| Schechter Adam H | President & CEO | Aug 11 | Open-market sale · S | −4,669 | $320.37 | −$1.5M | 102,565 |
| Summy Amy B. | EVP, Chief Marketing Officer | Aug 04 | Open-market sale · S | −924 | $306.74 | −$283K | 6,956 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Aug 03 | Open-market sale · S | −1,338 | $309.23 | −$414K | 1,770 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Aug 03 | Exercise / conversion · M | +1,338 | $209.25 | +$280K | 3,108 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Aug 03 | Open-market sale · S | −82 | $309.22 | −$25.4K | 1,770 |
| Kyle Kathryn W | EVP, Chief Legal Officer | Jul 02 | Open-market sale · S | −92 | $286.19 | −$26.3K | 3,904 |
| Vaughn Bryan T | EVP and President, Diagnostics | Jul 02 | Open-market sale · S | −234 | $286.19 | −$67K | 6,746 |
| Kyle Kathryn W | EVP, Chief Legal Officer | Jul 01 | Withheld — tax / exercise cost · F | −73 | $283.88 | −$20.7K | 3,996 |
| Kyle Kathryn W | EVP, Chief Legal Officer | Jul 01 | Exercise / conversion · M | +256 | — | — | 4,069 |
| Vaughn Bryan T | EVP and President, Diagnostics | Jul 01 | Withheld — tax / exercise cost · F | −93 | $283.88 | −$26.4K | 6,980 |
| Vaughn Bryan T | EVP and President, Diagnostics | Jul 01 | Exercise / conversion · M | +327 | — | — | 7,073 |
| Kyle Kathryn W | EVP, Chief Legal Officer | Jun 08 | Open-market sale · S | −762 | $263.89 | −$201K | 3,813 |
Loading...